Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized Treatment for Locally Advanced Breast Cancer
NCT02297230Phase 2Terminated
- Sponsor
- NYU Langone Health
- Start
- Jun 2002
- Primary completion
- Dec 2014
- Modality
- Antibody Conjugates, Monoclonal Antibodies, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, Paclitaxel Micelles for Injection, trastuzumab in breast cancer, sponsored by NYU Langone Health. Started Jun 2002; status: terminated.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02297230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02297230.